These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9453613)

  • 1. Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.
    George KM; Barker LP; Welty DM; Small PL
    Infect Immun; 1998 Feb; 66(2):587-93. PubMed ID: 9453613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
    George KM; Chatterjee D; Gunawardana G; Welty D; Hayman J; Lee R; Small PL
    Science; 1999 Feb; 283(5403):854-7. PubMed ID: 9933171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.
    George KM; Pascopella L; Welty DM; Small PL
    Infect Immun; 2000 Feb; 68(2):877-83. PubMed ID: 10639458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.
    Daniel AK; Lee RE; Portaels F; Small PL
    Infect Immun; 2004 Jan; 72(1):123-32. PubMed ID: 14688089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.
    Gama JB; Ohlmeier S; Martins TG; Fraga AG; Sampaio-Marques B; Carvalho MA; Proença F; Silva MT; Pedrosa J; Ludovico P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3066. PubMed ID: 25101965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
    Mve-Obiang A; Lee RE; Umstot ES; Trott KA; Grammer TC; Parker JM; Ranger BS; Grainger R; Mahrous EA; Small PL
    Infect Immun; 2005 Jun; 73(6):3307-12. PubMed ID: 15908356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and Characterization of Extracellular Vesicles from Mycobacterium ulcerans Culture.
    Foulon M; Marion E; Marsollier L
    Methods Mol Biol; 2022; 2387():41-51. PubMed ID: 34643900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buruli ulcer: emerging from obscurity.
    Wansbrough-Jones M; Phillips R
    Lancet; 2006 Jun; 367(9525):1849-58. PubMed ID: 16753488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.
    Torrado E; Fraga AG; Logarinho E; Martins TG; Carmona JA; Gama JB; Carvalho MA; Proença F; Castro AG; Pedrosa J
    J Immunol; 2010 Jan; 184(2):947-55. PubMed ID: 20008288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and cytotoxic activity by Mycobacterium ulcerans in protein-free media.
    Mve-Obiang A; Remacle J; Palomino JC; Houbion A; Portaels F
    FEMS Microbiol Lett; 1999 Dec; 181(1):153-7. PubMed ID: 10564801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of apoptosis in human Mycobacterium ulcerans culture-positive buruli ulcer skin lesions.
    Walsh DS; Meyers WM; Portaels F; Lane JE; Mongkolsirichaikul D; Hussem K; Gosi P; Myint KS
    Am J Trop Med Hyg; 2005 Aug; 73(2):410-5. PubMed ID: 16103613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis.
    Marsollier L; Brodin P; Jackson M; Korduláková J; Tafelmeyer P; Carbonnelle E; Aubry J; Milon G; Legras P; André JP; Leroy C; Cottin J; Guillou ML; Reysset G; Cole ST
    PLoS Pathog; 2007 May; 3(5):e62. PubMed ID: 17480118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer.
    Stinear TP; Seemann T; Pidot S; Frigui W; Reysset G; Garnier T; Meurice G; Simon D; Bouchier C; Ma L; Tichit M; Porter JL; Ryan J; Johnson PD; Davies JK; Jenkin GA; Small PL; Jones LM; Tekaia F; Laval F; Daffé M; Parkhill J; Cole ST
    Genome Res; 2007 Feb; 17(2):192-200. PubMed ID: 17210928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Curr Opin Infect Dis; 2010 Oct; 23(5):445-55. PubMed ID: 20581668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry of mycolactones, the causative toxins of Buruli ulcer.
    Kishi Y
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
    Torrado E; Adusumilli S; Fraga AG; Small PL; Castro AG; Pedrosa J
    Infect Immun; 2007 Aug; 75(8):3979-88. PubMed ID: 17517872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.